Cargando…

The Amyloid Precursor Protein (APP) Does Not Have a Ferroxidase Site in Its E2 Domain

The ubiquitous 24-meric iron-storage protein ferritin and multicopper oxidases such as ceruloplasmin or hephaestin catalyze oxidation of Fe(II) to Fe(III), using molecular oxygen as oxidant. The ferroxidase activity of these proteins is essential for cellular iron homeostasis. It has been reported t...

Descripción completa

Detalles Bibliográficos
Autores principales: Honarmand Ebrahimi, Kourosh, Dienemann, Christian, Hoefgen, Sandra, Than, Manuel E., Hagedoorn, Peter-Leon, Hagen, Wilfred R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747053/
https://www.ncbi.nlm.nih.gov/pubmed/23977245
http://dx.doi.org/10.1371/journal.pone.0072177
_version_ 1782280854559522816
author Honarmand Ebrahimi, Kourosh
Dienemann, Christian
Hoefgen, Sandra
Than, Manuel E.
Hagedoorn, Peter-Leon
Hagen, Wilfred R.
author_facet Honarmand Ebrahimi, Kourosh
Dienemann, Christian
Hoefgen, Sandra
Than, Manuel E.
Hagedoorn, Peter-Leon
Hagen, Wilfred R.
author_sort Honarmand Ebrahimi, Kourosh
collection PubMed
description The ubiquitous 24-meric iron-storage protein ferritin and multicopper oxidases such as ceruloplasmin or hephaestin catalyze oxidation of Fe(II) to Fe(III), using molecular oxygen as oxidant. The ferroxidase activity of these proteins is essential for cellular iron homeostasis. It has been reported that the amyloid precursor protein (APP) also has ferroxidase activity. The activity is assigned to a ferroxidase site in the E2 domain of APP. A synthetic 22-residue peptide that carries the putative ferroxidase site of E2 domain (FD1 peptide) has been claimed to encompass the same activity. We previously tested the ferroxidase activity of the synthetic FD1 peptide but we did not observe any activity above the background oxidation of Fe(II) by molecular oxygen. Here we used isothermal titration calorimetry to study Zn(II) and Fe(II) binding to the natural E2 domain of APP, and we employed the transferrin assay and oxygen consumption measurements to test the ferroxidase activity of the E2 domain. We found that this domain neither in the presence nor in the absence of the E1 domain binds Fe(II) and it is not able to catalyze the oxidation of Fe(II). Binding of Cu(II) to the E2 domain did not induce ferroxidase activity contrary to the presence of redox active Cu(II) centers in ceruloplasmin or hephaestin. Thus, we conclude that E2 or E1 domains of APP do not have ferroxidase activity and that the potential involvement of APP as a ferroxidase in the pathology of Alzheimer’s disease must be re-evaluated.
format Online
Article
Text
id pubmed-3747053
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37470532013-08-23 The Amyloid Precursor Protein (APP) Does Not Have a Ferroxidase Site in Its E2 Domain Honarmand Ebrahimi, Kourosh Dienemann, Christian Hoefgen, Sandra Than, Manuel E. Hagedoorn, Peter-Leon Hagen, Wilfred R. PLoS One Research Article The ubiquitous 24-meric iron-storage protein ferritin and multicopper oxidases such as ceruloplasmin or hephaestin catalyze oxidation of Fe(II) to Fe(III), using molecular oxygen as oxidant. The ferroxidase activity of these proteins is essential for cellular iron homeostasis. It has been reported that the amyloid precursor protein (APP) also has ferroxidase activity. The activity is assigned to a ferroxidase site in the E2 domain of APP. A synthetic 22-residue peptide that carries the putative ferroxidase site of E2 domain (FD1 peptide) has been claimed to encompass the same activity. We previously tested the ferroxidase activity of the synthetic FD1 peptide but we did not observe any activity above the background oxidation of Fe(II) by molecular oxygen. Here we used isothermal titration calorimetry to study Zn(II) and Fe(II) binding to the natural E2 domain of APP, and we employed the transferrin assay and oxygen consumption measurements to test the ferroxidase activity of the E2 domain. We found that this domain neither in the presence nor in the absence of the E1 domain binds Fe(II) and it is not able to catalyze the oxidation of Fe(II). Binding of Cu(II) to the E2 domain did not induce ferroxidase activity contrary to the presence of redox active Cu(II) centers in ceruloplasmin or hephaestin. Thus, we conclude that E2 or E1 domains of APP do not have ferroxidase activity and that the potential involvement of APP as a ferroxidase in the pathology of Alzheimer’s disease must be re-evaluated. Public Library of Science 2013-08-19 /pmc/articles/PMC3747053/ /pubmed/23977245 http://dx.doi.org/10.1371/journal.pone.0072177 Text en © 2013 Honarmand Ebrahimi et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Honarmand Ebrahimi, Kourosh
Dienemann, Christian
Hoefgen, Sandra
Than, Manuel E.
Hagedoorn, Peter-Leon
Hagen, Wilfred R.
The Amyloid Precursor Protein (APP) Does Not Have a Ferroxidase Site in Its E2 Domain
title The Amyloid Precursor Protein (APP) Does Not Have a Ferroxidase Site in Its E2 Domain
title_full The Amyloid Precursor Protein (APP) Does Not Have a Ferroxidase Site in Its E2 Domain
title_fullStr The Amyloid Precursor Protein (APP) Does Not Have a Ferroxidase Site in Its E2 Domain
title_full_unstemmed The Amyloid Precursor Protein (APP) Does Not Have a Ferroxidase Site in Its E2 Domain
title_short The Amyloid Precursor Protein (APP) Does Not Have a Ferroxidase Site in Its E2 Domain
title_sort amyloid precursor protein (app) does not have a ferroxidase site in its e2 domain
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747053/
https://www.ncbi.nlm.nih.gov/pubmed/23977245
http://dx.doi.org/10.1371/journal.pone.0072177
work_keys_str_mv AT honarmandebrahimikourosh theamyloidprecursorproteinappdoesnothaveaferroxidasesiteinitse2domain
AT dienemannchristian theamyloidprecursorproteinappdoesnothaveaferroxidasesiteinitse2domain
AT hoefgensandra theamyloidprecursorproteinappdoesnothaveaferroxidasesiteinitse2domain
AT thanmanuele theamyloidprecursorproteinappdoesnothaveaferroxidasesiteinitse2domain
AT hagedoornpeterleon theamyloidprecursorproteinappdoesnothaveaferroxidasesiteinitse2domain
AT hagenwilfredr theamyloidprecursorproteinappdoesnothaveaferroxidasesiteinitse2domain
AT honarmandebrahimikourosh amyloidprecursorproteinappdoesnothaveaferroxidasesiteinitse2domain
AT dienemannchristian amyloidprecursorproteinappdoesnothaveaferroxidasesiteinitse2domain
AT hoefgensandra amyloidprecursorproteinappdoesnothaveaferroxidasesiteinitse2domain
AT thanmanuele amyloidprecursorproteinappdoesnothaveaferroxidasesiteinitse2domain
AT hagedoornpeterleon amyloidprecursorproteinappdoesnothaveaferroxidasesiteinitse2domain
AT hagenwilfredr amyloidprecursorproteinappdoesnothaveaferroxidasesiteinitse2domain